Laboratory testing of donors and stool samples for fecal microbiota transplantation for recurrent clostridium difficile infection

60Citations
Citations of this article
126Readers
Mendeley users who have this article in their library.

Abstract

Fecal microbiota transplantation is an efficacious and inexpensive therapy for recurrent Clostridium difficile infection, yet its safety is thought to depend on appropriate fecal donor screening. FDA guidance for regulation of this procedure is in flux, but screening and manufacture of fecal material from asymptomatic donors present many challenges to clinical laboratories. This minireview summarizes FDA regulatory changes, principles of donor selection, and recommended laboratory screening practices for fecal microbiota transplantation.

Cite

CITATION STYLE

APA

Woodworth, M. H., Neish, E. M., Miller, N. S., Dhere, T., Burd, E. M., Carpentieri, C., … Kraft, C. S. (2017). Laboratory testing of donors and stool samples for fecal microbiota transplantation for recurrent clostridium difficile infection. Journal of Clinical Microbiology, 55(4), 1002–1010. https://doi.org/10.1128/JCM.02327-16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free